Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product

Conditions:   Non Hodgkin Lymphoma;   Multiple Myeloma;   Chronic Lymphocytic Leukemia;   Diffuse Large B Cell Lymphoma;   Mantle Cell Lymphoma;   Follicular Lymphoma Interventions:   Genetic: JCAR017;   Genetic: JCARH125 Sponsor:   Juno Therapeutics, Inc. Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials